On March 21, Gu Long Hui reported that Ark Health (06086.HK) announced its annual performance, with the group's revenue for the year ending December 31, 2024, at RMB 2.707 billion, a year-on-year increase of 11.22%; the adjusted net profit for 2024 significantly grew by 139% compared to 2023, benefiting from continuous technological enhancements and improved operational efficiency.
During the reporting period, the health platform experienced strong growth and increased user engagement. As of December 31, 2024, the number of registered users on the platform grew to 49.2 million. For the twelve months ending December 31, 2024, the average monthly active users reached 10.1 million, a year-on-year increase of 20%. Furthermore, the group's platform successfully connected with the social medical insurance system, enabling online medical insurance payment channels.
Thanks to the group's success in cultivating user loyalty, the repeat purchase rate of paying users for the twelve months ending December 31, 2024, remained strong at 84.7%. Consistent with the group's commitment to serving patients with chronic diseases, the total transaction amount of prescription drug commodities accounted for a significant portion of the total commodity transaction amount, at 81.3% for the year ending December 31, 2024.
